1887

Abstract

The application of CRISPR/Cas9 to improve genome engineering efficiency for large dsDNA viruses has been extensively described, but a robust and versatile method for high-throughput generation of marker-free recombinants for a desired locus has not yet been reported. Cytoplasmic-replicating viruses use their own repair enzymes for homologous recombination, while nuclear-replicating viruses use the host repair machinery. This is translated into a wide range of Cas9-induced homologous recombination efficiencies, depending on the virus replication compartment and viral/host repair machinery characteristics and accessibility. However, the use of Cas9 as a selection agent to target parental virus genomes robustly improves the selection of desired recombinants across large dsDNA viruses. We used ectromelia virus (ECTV) and herpes simplex virus (HSV) type 1 and 2 to optimize a CRISPR/Cas9 method that can be used versatilely for efficient genome editing and selection of both cytoplasmic- and nuclear-replicating viruses. We performed a genome-wide genetic variant analysis of mutations located at predicted off-target sequences for 20 different recombinants, showing off-target-free accuracy by deep sequencing. Our results support this optimized method as an efficient, accurate and versatile approach to enhance the two critical factors of high-throughput viral genome engineering: generation and colour-based selection of recombinants. This application of CRISPR/Cas9 reduces the time and labour for screening of desired recombinants, allowing for high-throughput generation of large collections of mutant dsDNA viruses for a desired locus, optimally in less than 2 weeks.

Funding
This study was supported by the:
  • Ministerio de Educación y Formación Profesional (Award FPU13/05425)
    • Principle Award Recipient: AlbertoDomingo López-Muñoz
  • European Regional Development Fund (Award RTI2018-097581-B100)
    • Principle Award Recipient: AntonioAlcami
  • Ministerio de Ciencia e Innovación (Award SAF2015-67485-R)
    • Principle Award Recipient: AntonioAlcami
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001797
2022-10-19
2024-05-04
Loading full text...

Full text loading...

/deliver/fulltext/jgv/103/10/jgv001797.html?itemId=/content/journal/jgv/10.1099/jgv.0.001797&mimeType=html&fmt=ahah

References

  1. Ebrahimi S, Teimoori A, Khanbabaei H, Tabasi M. Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome. Rev Med Virol 2019; 29:e2009 [View Article]
    [Google Scholar]
  2. Borca MV, Holinka LG, Berggren KA, Gladue DP. CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses. Sci Rep 2018; 8:3154 [View Article]
    [Google Scholar]
  3. Abkallo HM, Svitek N, Oduor B, Awino E, Henson SP et al. Rapid CRISPR/Cas9 editing of genotype IX African Swine fever virus circulating in Eastern and Central Africa. Front Genet 2021; 12:733674 [View Article]
    [Google Scholar]
  4. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013; 8:2281–2308 [View Article]
    [Google Scholar]
  5. Tanaka M, Kodaira H, Nishiyama Y, Sata T, Kawaguchi Y. Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes. Microbes Infect 2004; 6:485–493 [View Article]
    [Google Scholar]
  6. Ramachandran S, Knickelbein JE, Ferko C, Hendricks RL, Kinchington PR. Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters. Virology 2008; 378:254–264 [View Article]
    [Google Scholar]
  7. Russell TA, Stefanovic T, Tscharke DC. Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR/Cas9 nucleases. J Virol Methods 2015; 213:18–25 [View Article]
    [Google Scholar]
  8. Gowripalan A, Smith S, Stefanovic T, Tscharke DC. Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool. Commun Biol 2020; 3:643 [View Article]
    [Google Scholar]
  9. Wang D, Wang X-W, Peng X-C, Xiang Y, Song S-B et al. CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research. Cancer Gene Ther 2018; 25:93–105 [View Article]
    [Google Scholar]
  10. Li Z, Bi Y, Xiao H, Sun L, Ren Y et al. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes. Virus Res 2018; 244:286–295 [View Article]
    [Google Scholar]
  11. Mavian C, López-Bueno A, Bryant NA, Seeger K, Quail MA et al. The genome sequence of ectromelia virus Naval and Cornell isolates from outbreaks in North America. Virology 2014; 462–463:218–226 [View Article]
    [Google Scholar]
  12. Rastrojo A, López-Muñoz AD, Alcamí A. Genome sequence of Herpes simplex virus 1 strain SC16. Genome Announc 2017; 5:e01392-16 [View Article]
    [Google Scholar]
  13. López-Muñoz AD, Rastrojo A, Alcamí A. Complete genome sequence of Herpes simplex virus 2 strain 333. Microbiol Resour Announc 2018; 7:e00870-18 [View Article]
    [Google Scholar]
  14. Kropp KA, López-Muñoz AD, Ritter B, Martín R, Rastrojo A et al. Herpes simplex virus 2 counteracts neurite outgrowth repulsion during infection in a nerve growth factor-dependent manner. J Virol 2020; 94:20 [View Article]
    [Google Scholar]
  15. MacPherson CR, Scherf A. Flexible guide-RNA design for CRISPR applications using Protospacer Workbench. Nat Biotechnol 2015; 33:805–806 [View Article]
    [Google Scholar]
  16. Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M et al. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol 2014; 32:1262–1267 [View Article]
    [Google Scholar]
  17. Hugerth LW, Muller EEL, Hu YOO, Lebrun LAM, Roume H et al. Systematic design of 18S rRNA gene primers for determining eukaryotic diversity in microbial consortia. PLoS One 2014; 9:e95567 [View Article]
    [Google Scholar]
  18. Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M. Development of a prokaryotic universal primer for simultaneous analysis of Bacteria and Archaea using next-generation sequencing. PLoS One 2014; 9:e105592 [View Article]
    [Google Scholar]
  19. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 2014; 30:2114–2120 [View Article]
    [Google Scholar]
  20. Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011; 27:863–864 [View Article]
    [Google Scholar]
  21. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357–359 [View Article]
    [Google Scholar]
  22. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES et al. Integrative genomics viewer. Nat Biotechnol 2011; 29:24–26 [View Article]
    [Google Scholar]
  23. López-Muñoz AD, Rastrojo A, Martín R, Alcamí A. Herpes simplex virus 2 (HSV-2) evolves faster in cell culture than HSV-1 by generating greater genetic diversity. PLoS Pathog 2021; 17:e1009541 [View Article]
    [Google Scholar]
  24. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012; 22:568–576 [View Article]
    [Google Scholar]
  25. Yuan M, Zhang W, Wang J, Al Yaghchi C, Ahmed J et al. Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system. J Virol 2015; 89:5176–5179 [View Article]
    [Google Scholar]
  26. Ghezraoui H, Piganeau M, Renouf B, Renaud J-B, Sallmyr A et al. Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell 2014; 55:829–842 [View Article]
    [Google Scholar]
  27. Su T, Liu F, Gu P, Jin H, Chang Y et al. A CRISPR-Cas9 assisted non-homologous end-joining strategy for one-step engineering of bacterial genome. Sci Rep 2016; 6:37895 [View Article]
    [Google Scholar]
  28. Kuny CV, Bowen CD, Renner DW, Johnston CM, Szpara ML. In vitro evolution of herpes simplex virus 1 (HSV-1) reveals selection for syncytia and other minor variants in cell culture. Virus Evol 2020; 6:veaa013 [View Article]
    [Google Scholar]
  29. Deng Z-L, Dhingra A, Fritz A, Götting J, Münch PC et al. Evaluating assembly and variant calling software for strain-resolved analysis of large DNA viruses. Brief Bioinform 2021; 22:bbaa123 [View Article]
    [Google Scholar]
  30. Bi Y, Sun L, Gao D, Ding C, Li Z et al. High-efficiency targeted editing of large viral genomes by RNA-guided nucleases. PLoS Pathog 2014; 10:e1004090 [View Article]
    [Google Scholar]
  31. Lin C, Li H, Hao M, Xiong D, Luo Y et al. Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing of HSV-1 virus in human cells. Sci Rep 2016; 6:34531 [View Article]
    [Google Scholar]
  32. Gong Y, Bi Y, Li Z, Li Y, Yao Y et al. High-efficiency nonhomologous insertion of a foreign gene into the herpes simplex virus genome. J Gen Virol 2020; 101:982–996 [View Article]
    [Google Scholar]
  33. Yuan M, Gao X, Chard LS, Ali Z, Ahmed J et al. A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9. Mol Ther Methods Clin Dev 2015; 2:15035 [View Article]
    [Google Scholar]
  34. Tolonen N, Doglio L, Schleich S, Krijnse Locker J. Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei. Mol Biol Cell 2001; 12:2031–2046 [View Article]
    [Google Scholar]
  35. Luteijn RD, Drexler I, Smith GL, Lebbink RJ, Wiertz EJHJ. Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol. J Gen Virol 2018; 99:790–804 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001797
Loading
/content/journal/jgv/10.1099/jgv.0.001797
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error